UBS crossed 3 percent in Azelis. Azelis stock sits 1.33 percent below its high

Published on 10/15/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Azelis stock costs EUR 13.30 on October 15, 2026, below its EUR 13.48 high. H1 revenue rose 3.20 percent to EUR 2.20 billion.

Ownership and operating signals

UBS crossed the 3.00 percent threshold in Azelis on October 8, 2026.
First-half 2026 revenue increased 3.20 percent to EUR 2.20 billion.
Azelis stock trades at EUR 13.30 at 10:14 a.m. CEST at Lang & Schwarz on October 15, 2026, below its 52-week high of EUR 13.48.

Azelis, BE0974400328, Illustration mit AI erstellt.

Azelis Group (ISIN BE0974400328) was trading at EUR 13.30 at Lang & Schwarz on October 15, 2026, at 10:14 a.m. CEST. The latest company-specific disclosure showed UBS Group AG crossing the 3.00 percent threshold in Azelis on October 8, 2026, according to Business Wire.

UBS stake adds a fresh signal

UBS held 927,902 Azelis voting shares, equal to 0.38 percent, and 6,414,850 equivalent financial instruments, equal to 2.63 percent. Together, the positions represented 3.01 percent of voting rights on October 6, 2026, the transaction date named in the disclosure. Azelis is listed on Euronext Brussels under ticker AZE and is included in the BEL 20 and BEL ESG indexes, according to Business Wire.

What does the growth mean?

The operating picture improved in the first half of 2026. Azelis generated revenue of EUR 2.20 billion, up 3.20 percent from the prior-year period, while adjusted EBITDA reached EUR 233.00 million, an increase of 2.60 percent. The figures came from the company's first-half earnings call published on July 30, 2026, carried by Yahoo Finance.

Cash generation was EUR 122.00 million in the same period, while net debt stood at EUR 1.60 billion at the end of June 2026. Management also set an objective of positive full-year adjusted EBITDA growth, giving the margin trend and working capital the main operating significance for the next update.

Next results arrive October 22

Jefferies analyst David Kerstens expected a 10.00 percent third-quarter EBITA recovery for Azelis to EUR 108.00 million and repeated a EUR 15.00 price target, according to Beursgorilla. The report also identifies October 22, 2026 as the date for Azelis results.

Stock and operating picture

Azelis stock was EUR 0.18 below the EUR 13.48 52-week high cited in the October 15 market quotation, a 1.33 percent gap based on the Lang & Schwarz price. The current level therefore leaves the upcoming results as the next concrete test of whether the first-half recovery can extend into the second half.

Azelis stock was trading at EUR 13.30 at Lang & Schwarz on October 15, 2026, at 10:14 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Azelis stock.